Back to Melanotan i research
melanotan i melanocortin agonist in vitro n preclinical 2026-04-25 PubMed

NDP-MSH Protects Brain Astrocytes from Fat-Induced Oxidative Damage

NDP-MSH reduces oxidative damage induced by palmitic acid in primary astrocytes.

Background

Palmitic acid, a common saturated fatty acid, is increasingly recognized as a potent inducer of lipotoxicity and severe oxidative stress across various cell types, including the highly sensitive and metabolically active brain cells known as astrocytes. This cellular damage, characterized by an imbalance between pro-oxidant and antioxidant systems, is strongly implicated in the pathogenesis and progression of numerous neurodegenerative conditions, such as Alzheimer's disease, and metabolic disorders that profoundly impact brain health. The accumulation of reactive oxygen species (ROS) can lead to irreversible damage to proteins, lipids, and DNA, ultimately compromising neuronal function and survival. Consequently, identifying and characterizing novel therapeutic strategies that can effectively mitigate palmitic acid-induced oxidative damage in astrocytes is of paramount importance for developing robust neuroprotective interventions and preserving cognitive function.

Study Design

Population
Brain astrocytes exposed to palmitic acid to induce lipotoxicity and oxidative stress.
Intervention
NDP-MSH (Melanotan I) treatment.
Comparator
Control culture without NDP-MSH.
Outcome
Protection of brain astrocytes from fat-induced oxidative damage.

melanotan i melanocortin agonist oxidative-stress
Source: pubmed:30712280 · Ingested 2026-04-25 · Digest: gemini-2.5-flash